You’re kindly invited to join us at the upcoming Australian and New Zealand Society of Nephrology (ANZSN) conference from 9-11 September 2013 in Brisbane and hear more about our commitment to HighVolumeHDF.
The 49th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology will be held at the Convention and Exhibition Centre in Brisbane from 9-11 September 2013. The three day program hosts a variety of national, as well as international speakers from Europe, South America and the US. The program will cover topics from emerging technologies to immune pathology and disease.
The main meeting will be preceded by the Nephrology Update Course on 7th and 8th of September. The course is directed at young nephrologists and trainees and will provide updates in dialysis, transplantation, and general nephrology.
Fresenius Medical Care is sponsoring the conference and would like to extend an invitation to you to meet our clinical team at the Fresenius Medical Care booth (#25 & 38). We are sharing our commitment to HighVolumeHDF as recently evidenced in the clinical Estudio de Supervivencia de Hemodiafitracion On-Line (On-Line Hemodiafiltracion Survival Study, ESHOL) Catalonian study along with our award winning 5008 therapy system offering HighVolumeHDF.
Our new renal online platform www.fmc-au.com will also be on display for you to experience at our booth. Join us and discover our new look and feel: Fresenius Medical Care – THE RENAL COMPANY.
For more information and to register for ANZSN 2013, click here.